The United States Agency for International Development (USAID) is seeking input through a Request for Information (RFI) focused on strengthening Medical Product Quality Assurance (QA) systems in low- and middle-income countries (LMICs). The objective of this RFI, numbered 7200AA23RFI00015, is to gather expert insights that will inform the design of future activities aimed at improving health outcomes globally, particularly in the context of regulatory system strengthening and local capacity development. This initiative is crucial for enhancing the resilience of health systems and ensuring the quality of medical products in LMICs. Responses to the RFI are due by October 13, 2023, and should be submitted electronically to ohs_marketresearch@usaid.gov, adhering to specified formatting guidelines. For further inquiries, interested parties may contact Imran Mahmud at imahmud@usaid.gov.

application/vnd.openxmlformats-officedocument.wordprocessingml.document

7200AA23RFI00015 - Questions (Word Version).docx

7200AA23RFI00015 - SMPQAS Activity Market Research.pdf

7200AA23RFI00015.bin

7200AA23RFI00015.pdf

The United States Agency for International Development (USAID) has issued a Request for Information (RFI) aimed at gathering insights on strengthening Medical Product Quality Assurance (QA) systems in low- and middle-income countries (LMICs). The RFI, numbered 7200AA23RFI00015, is part of a market research initiative by the Bureau for Global Health, with responses due by October 13, 2023. The purpose is to collect expert input to inform future activity design and improve health outcomes globally.

Respondents are encouraged to provide commentary on key barriers to assuring medical product quality, opportunities for enhancement, and innovations to consider. Specific questions target areas such as regulatory system strengthening, responsible growth in pharmaceutical markets, local capacity strengthening, and engaging multisectoral actors. The submission guidelines stipulate a maximum length of 15 pages and certain formatting requirements. 

Importantly, this RFI does not solicit funding proposals and indicates no commitment by the U.S. Government to procure any services. USAID emphasizes that responses are voluntary and that information shared may be used without obligation. The initiative reflects a strategic approach to improve health system resilience and product quality in LMICs, focusing on sustainable practices and regulatory capacity development.

PLEASE REVIEW FULL RFI PDF and QUESTIONS FILES IN THE RELATED DOCUMENTS TAB OF THIS NOTICE.  **  Request for Information Number: 7200AA23RFI00015 Issuance Date: September 29, 2023 Closing Date: October 13, 2023, 17:00 Eastern/Washington, DC Time  Subject: Strengthening Medical Product Quality Assurance (QA) Systems Activity Market Research, Bureau for Global Health  To: All Interested Respondents/Parties:   The United States Agency for International Development (USAID) through the Bureau for Global Health (GH) is publishing this Request for Information (RFI) to obtain information and input from all interested entities for the Strengthening Medical Product Quality Assurance (QA) Systems Activity. The information will be used to help make planning decisions and may inform activity design to improve future development outcomes.  This RFI is issued to collect expert industry inputs solely for information-gathering and planning purposes. This RFI does not constitute a Request for Applications (RFA) or a Request for Proposals (RFP). Responses to this RFI are not applications or official proposals and will in no way be deemed to form any binding agreement with the RFI-issuing authority. Please do not submit applications, proposals, or resumes as they will be discarded. Proprietary information should not be sent. USAID may use any information provided without incurring any obligation. USAID reserves the right to, or not to, incorporate any, some, or none of the comments received from this RFI into any subsequent solicitations or design documents.  Anticipated Term: TBD Proposed Mechanism Type: TBD   THIS IS NOT A FUNDING OPPORTUNITY. This RFI must not be construed as a commitment by the U.S. Government to issue any solicitation, award any grant, or pay for any information submitted as a result of this request. Responders are solely responsible for bearing all expenses associated with preparation and submission of the response to this RFI.  It is the potential responder&apos;s responsibility to monitor the site for the release of any further information. It should be noted that responding to this RFI will not give any advantage to any organization in any subsequent procurement. All types of organizations and firms are strongly encouraged to provide information/comments. Any information submitted in response to this notice is voluntary.  All responses must be submitted electronically in accordance with the instructions provided in the RFI in English to ohs_marketresearch@usaid.gov. Responses to this RFI will be accepted through the dates noted at the top of this letter. No basis for claims against the U.S. Government shall arise as a result of a response to this request for information or from the U.S. Government&#8217;s use of such information. USAID is not responsible for any costs incurred in responding to this RFI.  RFI and Submission Instructions:  Through this RFI, GH seeks ideas, comments, and information from the public on medical product QA systems strengthening that will assist in developing a program that will most effectively advance the topic areas described below. GH asks that the public submit short submissions (must be no more than 15 pages) outlining recommendations or other information pertinent to the design and implementation of sustainable medical product QA systems at the global/regional and/or country level. Responses should clearly tie back to whatever question is being addressed, but submissions do not need to address all questions listed. All responses should provide sufficient detail and justification explaining why a certain recommendation is offered. Please also provide your name, title, organization, and contact information in the response. USAID reserves the right to potentially issue subsequent RFIs on this topic that target more specific questions or approaches. All submissions must adhere to the following to ensure an efficient review:   Must be in English, size 11 Calibri font, no more than 15 pages total. Graphics&#8217; subtext may use a smaller font size. Submission file should be in PDF or Microsoft Word format. Submission file should be saved as &#8220;7200AA23RFI00015 - (Respondent Organization)&#8221;.  Subject line for submission email must include [7200AA23RFI00015] Must be submitted to ohs_marketresearch@usaid.gov by the Closing Date and Time noted at the top of this letter.    Thank you for your interest in responding to this RFI. Please visit www.workwithusaid.org to learn more about partnering with USAID.

Buyer

Eligible Applicants

Funding Category

Funding Instrument

Opportunity Category

Cost Sharing or Matching Requirement

Original Source